Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population

Authors

Published

August 28, 2024

Abstract

The population prevalence of cardiac transthyretin amyloidosis (ATTR) caused by pathogenic variation in the TTR gene (vATTR) is unknown.

Supporters

Support the authors with ResearchCoin

Journal

JAMA Cardiology

Topics

DOI

10.1001/jamacardio.2024.2190

Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population

Authors

bhone myat

Published

August 28, 2024

Abstract

The population prevalence of cardiac transthyretin amyloidosis (ATTR) caused by pathogenic variation in the TTR gene (vATTR) is unknown.

Supporters

Support the authors with ResearchCoin

Journal

JAMA Cardiology

Topics

DOI

10.1001/jamacardio.2024.2190

Paper

Paper

Paper

Paper

Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population

Abstract

Supporters

Journal

Topics

DOI

Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population

Abstract

Supporters

Journal

Topics

DOI